Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| QLT INC/BC | 570 | reported | 09 May 2019 | tx 8+126,776−524 |
| Aegerion Pharmaceuticals, Inc. | 0 | reported | 29 Nov 2016 | tx 3−86,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 May 2019 | TAX_WITHHOLDING | QLT INC/BC | 77 | 1.22 USD | |
| 09 May 2018 | TAX_WITHHOLDING | QLT INC/BC | 80 | 4.26 USD | |
| 12 Feb 2018 | GRANT_AWARD | QLT INC/BC | 25,000 | 0.00 USD | deriv |
| 09 May 2017 | TAX_WITHHOLDING | QLT INC/BC | 93 | 9.42 USD | |
| 09 May 2017 | EXERCISE | QLT INC/BC | 274 | — | |
| 09 May 2017 | EXERCISE | QLT INC/BC | 274 | 0.00 USD | deriv |
| 22 Dec 2016 | GRANT_AWARD | QLT INC/BC | 97,400 | 0.00 USD | deriv |
| 29 Nov 2016 | GRANT_AWARD | QLT INC/BC | 4,102 | — | deriv |
| 29 Nov 2016 | OTHER | Aegerion Pharmaceuticals, Inc. | 4,000 | — | deriv |
| 29 Nov 2016 | OTHER | Aegerion Pharmaceuticals, Inc. | 7,000 | — | deriv |
| 29 Nov 2016 | OTHER | Aegerion Pharmaceuticals, Inc. | 75,000 | — | deriv |